2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Breast Neoplasms
43
Neoplasms
24
Motor Activity
12
Pain, Postoperative
9
Colorectal Neoplasms
9
Stomach Neoplasms
8
Lung Neoplasms
8
Fatigue
7
Anxiety Disorders
6
Pain
5
Carcinoma, Hepatocellular
5
Rectal Neoplasms
4
Polycystic Ovary Syndrome
4
Leukemia, Myeloid, Acute
4
Depression
4
Colonic Neoplasms
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Stomatitis
3
Squamous Cell Carcinoma of Head and Neck
3
Sleep Initiation and Maintenance Disorders
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Neoplasms
3
Malnutrition
3
Liver Neoplasms
3
Head and Neck Neoplasms
3
Agnosia
3
Vomiting
2
Urinary Incontinence
2
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
9
Ciprofloxacin
8
Voriconazole
5
Vancomycin
4
Caspofungin
4
Amoxicillin-Potassium Clavulanate Combination
4
gamma-Globulins
3
Fluconazole
3
Filgrastim
3
Daptomycin
3
Antibiotic Prophylaxis
3
plerixafor
2
liposomal amphotericin B
2
Whole-Body Irradiation
2
Trimethoprim
2
Therapeutics
2
Sulfamethoxazole
2
Saline Solution
2
Ribavirin
2
Polymerase Chain Reaction
2
Piperacillin, Tazobactam Drug Combination
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Moxifloxacin
2
Melphalan
2
Levofloxacin
2
Lenalidomide
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
Control Groups
×
Clear all
NCT06655506
2024-10-23
ERGO
National and Kapodistrian University of Athens
Recruiting
600 enrolled